Difference between revisions of "Part:BBa K4329002"
m |
m (→what is it?) |
||
| Line 3: | Line 3: | ||
<partinfo>BBa_K4329002 short</partinfo> | <partinfo>BBa_K4329002 short</partinfo> | ||
| − | === | + | ===What is it?=== |
| − | CRISPR/dCas9 is a gene editing technology used to inhibit the expression from the targeted sequence inducing DNA to activate its self-repair process. | + | CRISPR/dCas9 is a gene editing technology used to inhibit the expression from the targeted sequence inducing DNA to activate its self-repair process. |
===What it does?=== | ===What it does?=== | ||
Revision as of 12:00, 28 September 2022
sgRNA for targeting Bifunctional BirA enzyme
What is it?
CRISPR/dCas9 is a gene editing technology used to inhibit the expression from the targeted sequence inducing DNA to activate its self-repair process.
What it does?
This system insures the maximum yield of biotin. We have designed a sgRNA sequence (AAGTCACCATACGTTAGTAC) targeting the Bifunctional BirA enzyme after the production of biotin to prevent biotin from further disintegration.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 19
- 1000COMPATIBLE WITH RFC[1000]